March 25 (Reuters) - Takeda Pharmaceutical Co Ltd 4502.T:
TAKEDA PHARMACEUTICAL CO LTD - TAKEDA ANNOUNCES NEXT STEPS IN ITS TRANSFORMATION TO STRENGTHEN COMPETITIVENESS AND ACCELERATE FUTURE GROWTH OUTLOOK
TAKEDA PHARMACEUTICAL CO LTD - THE TRANSFORMATION, ALIGNED WITH THE PREVIOUSLY ANNOUNCED ORGANIZATIONAL STRUCTURE, IS EXPECTED TO DELIVER ANNUALIZED GROSS SAVINGS OF MORE THAN JPY 200 BILLION BY FY2028
TAKEDA PHARMACEUTICAL CO LTD - CURRENTLY ESTIMATES IT WILL INCUR RESTRUCTURING EXPENSES OF APPROXIMATELY JPY 150 BILLION IN FY2026, WITH LOWER RESTRUCTURING EXPENSES ALSO ANTICIPATED IN FY2027 AND FY2028
TAKEDA PHARMACEUTICAL CO LTD - DETAILS AND TIMING OF SPECIFIC INITIATIVES WILL BE DETERMINED IN DUE COURSE
Source text: ID:nTSoy8fca3
Further company coverage: 4502.T